Characteristics of type 2 asthma phenotypes and oral corticosteroid (OCS) use in the International Severe Asthma Registry (ISAR) (STAR)

05/10/2022
02/07/2024
EU PAS number:
EUPAS49201
Study
Ongoing
Documents
Study protocol
No information provided.
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
Composition of steering group and observers
English (17.94 KB - PDF) View document